KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Emergent BioSolutions (EBS) over the last 16 years, with Q3 2025 value amounting to -$200000.0.

  • Emergent BioSolutions' Exchange Rate Effect changed N/A to -$200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 10666.67%. This contributed to the annual value of -$1.2 million for FY2023, which is 34000.0% down from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Exchange Rate Effect is -$200000.0.
  • Emergent BioSolutions' Exchange Rate Effect's 5-year high stood at $1.1 million during Q4 2022, with a 5-year trough of -$1.5 million in Q4 2023.
  • In the last 4 years, Emergent BioSolutions' Exchange Rate Effect had a median value of -$200000.0 in 2021 and averaged -$64285.7.
  • Per our database at Business Quant, Emergent BioSolutions' Exchange Rate Effect plummeted by 40000.0% in 2021 and then skyrocketed by 25000.0% in 2022.
  • Emergent BioSolutions' Exchange Rate Effect (Quarter) stood at -$200000.0 in 2021, then surged by 650.0% to $1.1 million in 2022, then tumbled by 236.36% to -$1.5 million in 2023, then soared by 86.67% to -$200000.0 in 2025.
  • Its Exchange Rate Effect was -$200000.0 in Q3 2025, compared to $1.0 million in Q2 2025 and -$700000.0 in Q1 2025.